Homeβ€ΊSearchβ€ΊActa Pharmacologica Sinica

Acta Pharmacologica Sinica

Springer Nature Β· United Kingdom Β· Est. 2005

ISSN1671-4083eISSN1745-7254
SJR Q1βœ“ WOS SCIEβœ“ Scopus / SJR
96
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (3 more)+18
Total96
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
151
days submission β†’ published
measured Β· last 19 articles Β· accept 111d
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei
2.691
H-Indexi
142
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
1.658
Total Worksi
4,490
Total Citationsi
168,485
2yr Mean Citednessi
6.46
Open Impact Factor alternative
Retractions
12
Source: Retraction Watch

Aims & Scope

APS (Acta Pharmacologica Sinica) encourages submissions from all areas of pharmacology and the life sciences. Topics of particular interest include, but are not limited to, anticancer pharmacology, cardiovascular and pulmonary pharmacology, clinical pharmacology, drug discovery, gastrointestinal and hepatic pharmacology, genitourinary, renal and endocrine pharmacology, immunopharmacology and inflammation, molecular and cellular pharmacology, neuropharmacology, pharmaceutics and pharmacokinetics.

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published2005
FrequencyMonthly
StatusActive (last: 2026)
Total Publications4,490
Publisher OrgSpringer Nature
Visit Journal Website

Submission Info

Peer Reviewβ€”
Review Timeβ€”
Acceptance Rateβ€”
OA Licenseβ€”
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes

Think.Check.Submit Compliance

6/12 Β· 50%
βœ…
Do you know the journal / publisher?
Springer Nature
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
1671-4083 / 1745-7254
βœ…
Indexed in a trusted database?
WoS, Scopus, PubMed
❌
Peer review process documented?
N/A
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
❌
Plagiarism detection in place?
N/A
❌
Listed in DOAJ (verified OA)?
N/A
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
132
6.2k
2019
248
15k
2020
258
10k
2021
202
7.2k
2022
167
4.6k
2023
232
3.5k
2024
257
1.1k
2025
161
50
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Medicine (miscellaneous)Q1
PharmacologyQ1
Pharmacology (medical)Q1

Subject Classification

Web of Science Categories

Chemistry, MultidisciplinaryPharmacology & Pharmacy

Scopus Categories

PharmacologyPharmacology (medical)Medicine (miscellaneous)

Research Topics (OpenAlex)

Autophagy in Disease and TherapyIon channel regulation and functionNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and SignalingNeuroinflammation and Neurodegeneration MechanismsTraditional Chinese Medicine AnalysisCell death mechanisms and regulationCardiac electrophysiology and arrhythmiasDrug Transport and Resistance MechanismsCancer, Hypoxia, and Metabolism

Frequently asked questions about Acta Pharmacologica Sinica

Is Acta Pharmacologica Sinica a predatory journal?

PubScope has no integrity flags on record for Acta Pharmacologica Sinica: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Acta Pharmacologica Sinica?

Acta Pharmacologica Sinica is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 6.46.

Is Acta Pharmacologica Sinica indexed in Scopus and Web of Science?

Acta Pharmacologica Sinica is indexed in Web of Science, Scopus.

What is the aims and scope of Acta Pharmacologica Sinica?

APS (Acta Pharmacologica Sinica) encourages submissions from all areas of pharmacology and the life sciences. Topics of particular interest include, but are not limited to, anticancer pharmacology, cardiovascular and pulmonary pharmacology, clinical pharmacology, drug discovery, gastrointestinal and hepatic pharmacology, genitourinary, renal and endocrine pharmacology, immunopharmacology and inflammation, molecular and cellular pharmacology, neuropharmacology, pharmaceutics and pharmacokinetics.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref